UMOJA
Live / Registered — Registered (as of 14 Oct 2025)
What this means for you
Registered since 14 Oct 2025. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 90126781
- Registration number
- 7985867
- Mark type
- Stylized text
- Filed
- 20 Aug 2020
- Published for opposition
- 03 Aug 2021
- Registered
- 14 Oct 2025
- Attorney of record
- Mark A. Jansen
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical products for the treatment of cancer
- Class 040 — Treatment of materials: Manufacturing services for others in the field of pharmaceutical preparations
- Class 042 — Scientific and technological services: Medical research and scientific research in the fields of immunotherapy and oncology; Medical research consulting and scientific research consulting services in the fields of immunotherapy and oncology
- Class 044 — Medical, beauty and agricultural services: Medical consulting services in the fields of immunotherapy and oncology
Owner
- Umoja Biopharma, Inc., Seattle, WA, US
- Umoja Biopharma, Inc., Seattle, WA, US
- Umoja Biopharma, Inc., Seattle, WA, US
Prosecution history
- 14 Oct 2025 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 14 Oct 2025 — REGISTERED-PRINCIPAL REGISTER
- 23 Sept 2025 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 23 Sept 2025 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 23 Sept 2025 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 23 Sept 2025 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 23 Sept 2025 — ASSIGNED TO LIE
- 16 Sept 2025 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 17 Jun 2025 — APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
- 17 Jun 2025 — APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
- 19 Mar 2025 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 19 Mar 2025 — NON-FINAL ACTION E-MAILED
- 19 Mar 2025 — SU - NON-FINAL ACTION - WRITTEN
- 18 Mar 2025 — ASSIGNED TO EXAMINER
- 07 Dec 2024 — STATEMENT OF USE PROCESSING COMPLETE